Evidence map›Paper›PMID 31611527›Full record

ArticleInternal medicine (Tokyo, Japan)2020

Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits without Conspicuous Mesangial Proliferation, Complicated with Squamous Cell Lung Carcinoma.

Takaaki Higashihara, Akira Okada, Yasuna Nakamura, Hanako Saigusa, Shiko Homma, Mimiko Matsumura, Taiko Kusano, Akira Shimizu, Hideki Takano

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Takaaki HigashiharaDepartment of Nephrology, Tokyo Teishin Hospital, Japan.
Akira OkadaDivison of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Japan.
Yasuna NakamuraDepartment of Nephrology, Tokyo Teishin Hospital, Japan.
Hanako SaigusaDepartment of Nephrology, Tokyo Teishin Hospital, Japan.
Shiko HommaDepartment of Nephrology, Tokyo Teishin Hospital, Japan.
Mimiko MatsumuraDepartment of Nephrology, Tokyo Teishin Hospital, Japan.
Taiko KusanoDepartment of Nephrology, Tokyo Teishin Hospital, Japan.
Akira ShimizuDepartment of Analytic Human Pathology, Graduate School of Medicine, Nippon Medical School, Japan.
Hideki TakanoDepartment of Nephrology, Tokyo Teishin Hospital, Japan.
Tokyo Teishin Hospital · JPThe University of Tokyo · JPNippon Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed a renal biopsy for nephrotic syndrome in a patient with squamous cell lung carcinoma, which can worsen the prognosis. Chemoradiation therapy was effective for the cancer and proteinuria; we thus inferred that the nephrotic syndrome had been closely associated with the carcinoma. A pathological analysis of the kidney showed monoclonality for λ chain, satisfying the diagnostic criteria of proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID); however, conspicuous mesangial proliferation was not observed. This is the first case of PGNMID complicated with lung carcinoma; furthermore, our findings underscore the importance of examining renal lesions and assessing monoclonality in cancer patients.

Indexed as

AgedAntibodies, MonoclonalCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellCell ProliferationEpithelial CellsGlomerulonephritis, MembranoproliferativeHumansImmunoglobulin GMaleAntibodies, MonoclonalImmunoglobulin Glung carcinomaparaneoplastic syndromeproliferative glomerulonephritis with monoclonal immunoglobulin deposits

Identifiers

PMID31611527
PMCPMC7056369
OpenAlexW2980661550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.